There’s a peculiar kind of confidence in the insurance industry right now. Dozens of carriers have rolled out dedicated AI liability products. Underwriters are busy drafting exclusion clauses for hallucinations, model drift, and algorithmic bias. Brokers are pitching “comprehensive AI coverage” to enterprise clients. And yet, if you ask any actuary with a direct line to their company’s AI desk how they’re pricing tail risk on a large language model deployment, you’ll get a long pause followed by something that sounds a lot like improvisation.
The AI insurance market isn’t in a bubble exactly — it’s in that earlier, stranger phase where everyone is playing the game confidently while knowing that the rulebook is still being written in pencil. Premiums are moving. Exclusions are multiplying. And startups building AI products are starting to discover that the coverage they bought may cover significantly less than the brochure implied.
This is the story of a market trying to insure a technology it doesn’t fully understand, under regulatory frameworks that don’t yet exist, using actuarial models built on almost no historical claims data.
The pitch for AI liability insurance usually sounds clean: you build an AI product, something goes wrong — a model hallucinates a dangerous medical dosage, a hiring algorithm discriminates, a fraud detection system flags the wrong account — and the policy covers the damage. Straightforward, right?
Except the fine print has been doing a lot of heavy lifting. Insurance industry analysts and legal observers have noted that most current AI policies contain exclusions that carve out exactly the scenarios enterprise buyers fear most. Errors originating from third-party foundation models — GPT-5, Gemini 2.5 Pro, Claude Opus 4.6, take your pick — are frequently excluded from first-party AI policies on the grounds that the policyholder didn’t build the underlying system. Model hallucinations, specifically, occupy a legal gray zone: is a hallucination an “error” by the software, a failure of the operator to implement proper guardrails, or simply expected behavior of a probabilistic system? Insurers have answered this question differently in different policy documents, and courts haven’t yet provided a definitive answer because the relevant case law barely exists.
The problem is structural. Traditional software liability insurance was built around deterministic systems — code that, given the same input, produces the same output. An AI model is not that. It’s a probabilistic function where the same prompt can produce materially different outputs across runs, and where “correct” output is often a matter of interpretation rather than specification. Writing an exclusion clause around that is harder than it sounds.
Marsh McLennan, one of the world’s largest insurance brokers, published guidance in 2023 noting that AI presented “a new class of liability exposure” that existing professional indemnity and technology errors-and-omissions (E&O) policies were “not designed to address.” Munich Re and AXA XL both developed dedicated AI-specific coverage products in 2023-2024, explicitly acknowledging the gap between what traditional policies covered and what AI deployments actually needed. The acknowledgment was honest. The pricing, by the carriers’ own admission, was speculative.
Insurance pricing relies on actuarial tables: historical loss data, frequency distributions, severity estimates. For car insurance, carriers have decades of accident data segmented by age, vehicle type, geography, and driving behavior. For AI liability, the industry is working with a dataset that amounts to roughly two years of commercial deployment, a handful of publicly reported incidents, and a lot of theoretical modeling.
This matters enormously for how premiums get set. When there’s no reliable loss history, underwriters don’t price to expected loss — they price to uncertainty. That means loading premiums with substantial risk margins to protect against the unknown, which in practice means early buyers of AI coverage have been paying for the insurer’s ignorance as much as for actual risk transfer.
The hallucination clause problem is particularly acute. In 2024, insurance trade publication Risk & Insurance reported that underwriters were actively debating whether AI hallucinations should be treated as a covered “error” under technology E&O policies or excluded as an inherent characteristic of the technology — comparable to how policies exclude losses from a car’s known tendency to depreciate. The debate hadn’t resolved by late 2024, and different carriers landed in different places. Some policies explicitly cover hallucination-related claims. Many more contain language vague enough that coverage depends entirely on how an adjuster and eventually a judge interprets the word “malfunction.”
For enterprises deploying AI in high-stakes domains — healthcare, legal, financial services — this ambiguity isn’t a minor inconvenience. It’s a liability strategy question. If your AI-assisted diagnostic tool produces a harmful recommendation and your insurer argues the hallucination was expected behavior rather than a product defect, you’re looking at an uncovered claim in exactly the scenario you bought the policy to address.
Regulators on both sides of the Atlantic have been accelerating their involvement in AI risk governance, and the insurance industry is watching closely because regulatory requirements tend to create mandatory coverage markets — and mandatory coverage markets lock in pricing structures before competitive dynamics mature.
The EU AI Act, which entered force in 2024 with phased implementation timelines, classifies certain AI applications as high-risk and imposes conformity assessment and documentation requirements that implicitly create insurance demand. High-risk AI system operators in the EU need to demonstrate financial capacity to cover potential damages — and while the Act doesn’t explicitly mandate insurance, legal advisors have broadly recommended coverage as the practical solution. This created a rush of European enterprises seeking AI-specific policies at exactly the moment when carrier capacity was still limited and exclusion clauses were still being drafted by lawyers who hadn’t finished reading the Act themselves.
In the United States, the regulatory picture is more fragmented. The NIST AI Risk Management Framework, the FTC’s ongoing AI guidance, sector-specific rules from the FDA for AI-enabled medical devices and from financial regulators for algorithmic trading — none of these created a single, clear insurance requirement, but collectively they created enough liability exposure that risk managers at large enterprises started treating AI coverage as a necessity rather than an option. The insurance market responded to that demand before it had the actuarial infrastructure to price it properly.
“The challenge with AI is that we’re being asked to underwrite technology that can fail in ways that aren’t predictable from the training data, in contexts we haven’t anticipated, producing harms that may be diffuse and difficult to attribute. That’s a genuinely hard insurance problem.” — Senior underwriter quoted in Insurance Insider, 2024
The regulatory pricing lock-in concern is real. Insurance markets have historical precedent for this: when mandatory coverage requirements arrive before the market has priced risk accurately, early pricing structures tend to persist longer than they should because carriers resist re-rating books of business that are now generating predictable premium income. For AI startups, this creates a potential scenario where coverage gets more expensive as the regulatory mandate tightens, just as their growth stage demands the most capital efficiency.
The response from the startup community has been predictably varied. Well-funded Series B and C companies with enterprise customers demanding insurance certificates have largely bought coverage — often through brokers who specialize in tech E&O — while quietly noting to their legal teams that the policies have more holes than they’d prefer. Earlier-stage companies have been more resistant, frequently concluding that the cost-benefit ratio of current AI policies doesn’t justify the premium.
The self-insurance argument has gained traction in some quarters. For a company whose AI product doesn’t operate in a regulated high-stakes domain — say, an AI writing assistant or a code generation tool — the argument goes that existing technology E&O and professional liability coverage is sufficient, the incremental AI-specific premium is paying for ambiguous additional coverage, and the capital is better deployed in safety engineering and human oversight systems that reduce the underlying risk rather than transfer it to an insurer who may deny the claim anyway.
There’s also a strategic timing argument. Several AI-focused legal advisors and risk consultants have publicly suggested that startups who can afford to wait should let the regulatory and legal landscape develop for another twelve to eighteen months before buying dedicated AI coverage. The reasoning: as the EU AI Act’s implementation milestones pass and as the first wave of significant AI liability litigation produces actual court decisions, the policy language will sharpen considerably. The hallucination clause ambiguity will get resolved. Exclusion language will become more standardized. And pricing will have actual claims data to anchor against rather than theoretical models. Buying now means paying the uncertainty premium. Buying in 2027 means buying a better product at a more rational price — assuming the regulatory timeline doesn’t force your hand before then.
For organizations that can’t afford to wait — regulated industries, companies with large enterprise contracts requiring coverage, businesses operating in high-risk AI application categories — the current market requires considerably more scrutiny than a standard technology insurance procurement process. The questions that matter most aren’t the ones in the carrier’s brochure.
The first is the foundation model question: does the policy cover harms that originate in the behavior of a third-party model that the policyholder is deploying but didn’t build? The answer in most current policies is “not clearly” or “not fully,” and the specific language needs to be reviewed by counsel who understands both AI systems and insurance contract interpretation. Given that the vast majority of commercial AI deployments in 2025-2026 run on top of models from OpenAI, Anthropic, Google, or Meta, this exclusion can functionally gut the coverage for the most likely claim scenarios.
The second is the incident attribution question: how does the policy handle harms where the causal chain runs through AI output but also involves human decisions? Most real-world AI liability scenarios aren’t clean cases of “the AI did a bad thing.” They’re messy chains where an AI system produced a recommendation, a human acted on it without sufficient review, and harm resulted. Current policies handle this inconsistently, and the allocation of responsibility between AI malfunction coverage and professional liability coverage creates gaps that claimants — or their lawyers — will find.
The third is the regulatory action question: does the policy cover regulatory fines and enforcement costs, not just third-party damages? As AI regulation tightens, the most immediate financial exposure for many enterprises may be regulatory penalties rather than civil litigation. EU AI Act fines can reach 3% to 7% of global annual turnover for serious violations. Many AI liability policies focus on third-party bodily injury and property damage claims and provide inadequate coverage for the regulatory exposure that may actually arrive first.
The immaturity of the AI insurance market is a signal about something larger than insurance pricing. Insurance markets are, at their best, a distributed risk-assessment mechanism — when coverage is cheap and readily available, that’s a signal that the market has priced the risk as manageable. When coverage is expensive, exclusion-heavy, and structurally ambiguous, that’s a signal that the market genuinely doesn’t know how dangerous the underlying activity is.
Right now, the AI insurance market is sending the second signal. That should matter to enterprises making deployment decisions, to regulators designing liability frameworks, and to AI developers building systems that will carry both their customers’ trust and, increasingly, their customers’ legal exposure. The actuarial uncertainty in AI insurance pricing is a direct reflection of the genuine uncertainty about how these systems fail, how often, in what contexts, and with what magnitude of harm.
The companies treating that uncertainty as merely a cost-of-business procurement problem are missing the more interesting question it raises. If the insurers — whose entire business model depends on accurately pricing risk — can’t figure out how to underwrite AI liability after two years of commercial deployment, it’s worth asking what that tells us about how well the rest of the industry understands the risk profile of the systems it’s shipping.
If you’re running a startup building AI products, the practical takeaway is this: the coverage you can buy today is better than nothing but worse than it claims to be. Get a broker who specializes in tech E&O and has specific experience placing AI policies — not a generalist who added “AI” to their pitch deck last year. Have legal counsel review exclusion language before signing, specifically for the foundation model exclusion and the hallucination/expected behavior clause. And don’t treat insurance as a substitute for actual safety engineering; the carriers who will emerge as long-term partners in this market are already discriminating between buyers who treat risk management seriously and buyers who just want a certificate of insurance to satisfy a procurement checklist.
For enterprises already holding AI policies, this is a good moment to dust off the policy document and ask your broker the three questions above. The answers will tell you a lot about whether what you bought is actually protecting you or mostly protecting the insurer’s book of business. The market will mature — regulatory requirements will sharpen, claims data will accumulate, pricing will rationalize — but that process will take years, and the policies being written today are the ones that will govern the claims that arrive before it happens.
The AI insurance market is doing what nascent markets always do: it’s improvising under uncertainty, charging for the privilege, and hoping the claims stay manageable until the actuarial models catch up with the technology. For the enterprises and startups navigating it, informed skepticism isn’t cynicism — it’s the only reasonable posture when buying coverage from an industry that’s still figuring out what it’s selling.
